KJ

Kanhaiya Jha

Active Director Director DIN 11917103
DIN 11917103 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanhaiya Jha

Kanhaiya Jha is a Director at Firsthood Health Private Limited (since 2026).

DIN 11917103
Primary Designation Director
First Appointment 28 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Firsthood Health Private Limited U62011BR2026PTC087656
Director28 Aug 20262026Active

Board colleagues of Kanhaiya Jha

NameDINCompanyDesignation
Chetan Ginigeri06883042Firsthood Health Private LimitedIndividual Subscriber
Devanand Kolothodi02598341Firsthood Health Private LimitedIndividual Subscriber
Harsh Kumar11917102Firsthood Health Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Firsthood Health Private Limited
Premium access

Shareholding and investment profile for Kanhaiya Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanhaiya Jha

Kanhaiya Jha currently holds 1 directorship: Firsthood Health Private Limited (Director, since 28 Aug 2026).

Kanhaiya Jha was first appointed on 28 Aug 2026 as Director at Firsthood Health Private Limited.

The current boards of Kanhaiya Jha's companies include Chetan Ginigeri (Firsthood Health Private Limited), Devanand Kolothodi (Firsthood Health Private Limited), Harsh Kumar (Firsthood Health Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available